Abstract: The present invention relates to a composition of a calcium phosphate such as tetracalcium phosphate or ?-TCP and an additive compound selected from nucleic acid or nucleotides, phospho(enol)pyruvic acid and phosphocreatine. The composition may be used as a tissue adhesive.
Type:
Grant
Filed:
November 30, 2018
Date of Patent:
March 12, 2024
Assignee:
GPBIO LTD.
Inventors:
Philip Procter, Michael Pujari-Palmer, Gerard Insley, HÃ¥kan Engqvist